Induction of renal arachidonate cytochrome P-450 epoxygenase after uninephrectomy: counterregulation of hyperfiltration. Takahashi K, Harris RC, Capdevila JH, Karara A, Makita K, Jacobson HR, Munger KA, Badr KF (1993) J Am Soc Nephrol 3: 1496-500 Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase. Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI (1993) J Clin Endocrinol Metab 77: 98-102 Mediation of renal vascular effects of epidermal growth factor by arachidonate metabolites. Harris RC, Munger KA, Badr KF, Takahashi K (1990) FASEB J 4: 1654-60 Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism. Cotton RB, Shah LP, Poole SD, Ehinger NJ, Brown N, Shelton EL, Slaughter JC, Baldwin HS, Paria BC, Reese J (2013) J Mol Cell Cardiol 59: 86-94 Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity. Hargrove TY, Garvey EP, Hoekstra WJ, Yates CM, Wawrzak Z, Rachakonda G, Villalta F, Lepesheva GI (2017) Antimicrob Agents Chemother 61: Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. Yamazaki H, Inoue K, Shaw PM, Checovich WJ, Guengerich FP, Shimada T (1997) J Pharmacol Exp Ther 283: 434-42 The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis. Yang S, Wei S, Pozzi A, Capdevila JH (2009) Arch Biochem Biophys 489: 82-91 Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Capdevila J, Gil L, Orellana M, Marnett LJ, Mason JI, Yadagiri P, Falck JR (1988) Arch Biochem Biophys 261: 257-63 Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions. Blobaum AL, Bridges TM, Byers FW, Turlington ML, Mattmann ME, Morrison RD, Mackie C, Lavreysen H, Bartolomé JM, Macdonald GJ, Steckler T, Jones CK, Niswender CM, Conn PJ, Lindsley CW, Stauffer SR, Daniels JS (2013) Drug Metab Dispos 41: 2066-75 Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents. Lamb DC, Kelly DE, Waterman MR, Stromstedt M, Rozman D, Kelly SL (1999) Yeast 15: 755-63
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.